Ledger.Open graph →
SEC Form D · filed December 12, 2016

Eureka Therapeutics Inc

Offering
$40.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Emeryville, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Cheng Liu · Emeryville, CAExec · DirectorSandy Chau · Emeryville, CADirectorVictor S. Pompino · NORWALK, CTDirectorNick B. Margarites · Washington, Washington, D.C.Exec · DirectorChih-Kai Cheng · Taipei, F5DirectorMichael Cannon · San Diego, CADirectorHsing Kung · Santa Clara, CADirectorQiushi Fu · Beijing, IsraelDirectorIsaac Flattau · New York, NYExec · DirectorJeffrey C. Seller · New York, NYDirectorChih-Kai Cheng · Santa Clara, CADirectorMichael Cannon · San Diego, CADirectorHsing Kung · Emeryville, CADirectorQiushi Fu · Emeryville, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗